Rapid Micro Biosystems, Inc. (RPID)

US — Healthcare Sector
Peers: RXST  AXGN  TMCI  LUNG  OFIX  AZYO  AIMD  SRDX  LNSR  IRIX  OSA  LIVN  ELMD  KIDS  OWLT  BVS  INVO  TLIS  BBLG  TIVC  BJDX  VVOS 

Automate Your Wheel Strategy on RPID

With Tiblio's Option Bot, you can configure your own wheel strategy including RPID - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol RPID
  • Rev/Share 0.6739
  • Book/Share 1.4887
  • PB 2.2369
  • Debt/Equity 0.0897
  • CurrentRatio 4.6134
  • ROIC -0.6604

 

  • MktCap 145959561.0
  • FreeCF/Share -0.8818
  • PFCF -3.7626
  • PE -3.2679
  • Debt/Assets 0.0688
  • DivYield 0
  • ROE -0.5607

 

  • Rating C
  • Score 2
  • Recommendation Sell
  • P/E Score 1
  • DCF Score 1
  • P/B Score 3
  • D/E Score 3

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
Initiation RPID KeyBanc Capital Markets -- Overweight -- $8 Feb. 12, 2025

News

Rapid Micro Biosystems, Inc. (RPID) Q1 2025 Earnings Call Transcript
RPID
Published: May 09, 2025 by: Seeking Alpha
Sentiment: Neutral

Rapid Micro Biosystems, Inc. (NASDAQ:RPID ) Q1 2025 Earnings Conference Call May 9, 2025 8:30 AM ET Company Participants Mike Beaulieu - VP, IR and Corporate Communications Rob Spignesi - President and CEO Sean Wirtjes - CFO Conference Call Participants Dan Arias - Stifel Paul Knight - KeyBanc Capital Markets Chad Wiatrowski - TD Cowen Operator Thank you for standing by. My name is RG, and I will be your conference operator today.

Read More
image for news Rapid Micro Biosystems, Inc. (RPID) Q1 2025 Earnings Call Transcript
Rapid Micro Biosystems, Inc. (RPID) Reports Q1 Loss, Tops Revenue Estimates
RPID
Published: May 09, 2025 by: Zacks Investment Research
Sentiment: Negative

Rapid Micro Biosystems, Inc. (RPID) came out with a quarterly loss of $0.26 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to loss of $0.31 per share a year ago.

Read More
image for news Rapid Micro Biosystems, Inc. (RPID) Reports Q1 Loss, Tops Revenue Estimates
Rapid Micro Biosystems Reports First Quarter 2025 Financial Results
RPID
Published: May 09, 2025 by: GlobeNewsWire
Sentiment: Neutral

LEXINGTON, Mass., May 09, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced its financial results for the first quarter ended March 31, 2025.

Read More
image for news Rapid Micro Biosystems Reports First Quarter 2025 Financial Results
Rapid Micro Biosystems, Inc. (RPID) Q4 2024 Earnings Call Transcript
RPID
Published: February 28, 2025 by: Seeking Alpha
Sentiment: Neutral

Rapid Micro Biosystems, Inc. (NASDAQ:RPID ) Q4 2024 Earnings Conference Call February 28, 2025 8:00 AM ET Company Participants Mike Beaulieu – Vice President, Investor Relations and Corporate Communications Rob Spignesi – President and Chief Executive Officer Sean Wirtjes – Chief Financial Officer Conference Call Participants Dan Arias – Stifel Paul Knight – KeyBanc Brendan Smith – TD Cowen Operator Thank you for standing by. My name is Eloisa, and I will be your conference operator today.

Read More
image for news Rapid Micro Biosystems, Inc. (RPID) Q4 2024 Earnings Call Transcript
Rapid Micro Biosystems, Inc. (RPID) Reports Q4 Loss, Tops Revenue Estimates
RPID
Published: February 28, 2025 by: Zacks Investment Research
Sentiment: Negative

Rapid Micro Biosystems, Inc. (RPID) came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Estimate of a loss of $0.24. This compares to loss of $0.26 per share a year ago.

Read More
image for news Rapid Micro Biosystems, Inc. (RPID) Reports Q4 Loss, Tops Revenue Estimates
Rapid Micro Biosystems Reports Fourth Quarter and Full Year 2024 Financial Results and Provides 2025 Guidance
RPID
Published: February 28, 2025 by: GlobeNewsWire
Sentiment: Neutral

LEXINGTON, Mass., Feb. 28, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced its financial results for the fourth quarter and full year ended December 31, 2024.

Read More
image for news Rapid Micro Biosystems Reports Fourth Quarter and Full Year 2024 Financial Results and Provides 2025 Guidance
Rapid Micro Biosystems to Announce Fourth Quarter and Full Year 2024 Financial Results on February 28, 2025
RPID
Published: February 20, 2025 by: GlobeNewsWire
Sentiment: Neutral

LEXINGTON, Mass., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, will release fourth quarter and full year 2024 financial results prior to the market open on Friday, February 28, 2025.

Read More
image for news Rapid Micro Biosystems to Announce Fourth Quarter and Full Year 2024 Financial Results on February 28, 2025

About Rapid Micro Biosystems, Inc. (RPID)

  • IPO Date 2021-07-15
  • Website https://www.rapidmicrobio.com
  • Industry Medical - Devices
  • CEO Mr. Robert G. Spignesi Jr.
  • Employees 163

Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in North America, Europe, and Asia. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and comprehensive customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides installation and verification, technical training, and support services. Its solutions are used in environmental monitoring, water testing, bioburden, and sterility release testing applications. The company was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. in January 2007. Rapid Micro Biosystems, Inc. was incorporated in 2006 and is headquartered in Lowell, Massachusetts.